SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?


To: John Lacelle who wrote (593)5/9/2001 11:10:22 AM
From: Harold Engstrom  Respond to of 1127
 
Jeeze, John, will you ever learn? <g>

HGSI is neither overhyped nor is it likely to suffer a demise. Its stock will likely go up and go down, but overall it will go up significantly over the next few years. This opinion is not one you can bank, but one you can bet on with some confidence.

I think HGSI might be a little ahead of itself - I sold in the low 50's - but I would buy again if it gets cheap again relative to the present state of its pipeline.

In any event, if you do persist in betting against the company with options, then I hope the stock momentarily takes a big dive - you can sell your options and I can buy some shares.

Good luck,

H



To: John Lacelle who wrote (593)5/9/2001 7:49:24 PM
From: KevRupert  Respond to of 1127
 
"Well, I am happy for you. I would recommend taking the profits...who can argue with a 50% gain?"

Hi John,

I'm not a trader -- otherwise I would take a profit. I am in HGSI for the long-term prospects of 1-5 big discoveries. It is stated by most biotech followers that HGSI has the most valuable patent pipeline in biotech. The company also has about $1.8 billion in cash -- and no debt.

I hope you are right in the short-term. I just couldn't see your rational that the TA was negative -- when it was up 50% in the past couple weeks.

Let's hope it goes down short-term for your benefit, and up for my benefit in the long-term. :)